urolithiasis
UROLITHIASIS

Urolithiasis is the formation of urinary stones in the kidney, bladder and/or urethra.

The hallmark of obstruction in the ureter and renal pelvis is the sudden onset of excruciating, intermittent pain that radiates from the flank to the groin or to the genital area and inner thigh.

It is a painful urologic disorder that occurs in 12% of the global population and has a high recurrence rate among male patients.

Lower urinary tract symptoms that are associated with urolithiasis are urgency, frequency, urge incontinence and dysuria.

 

Follow Up

  • Obtain a single 24-hour urine specimen for known stone-formers w/in 5 months after the initiation of treatment
    • Assess the response to dietary &/or medical therapy
  • After the initial follow-up, a 24-hour urine specimen should be obtained annually or w/ greater frequency, depending on the stone activity
    • Assess patient’s adherence & metabolic response
  • Obtain periodic blood testing
  • Advise the patient to increase intake of fruits & vegetables
  • Assess for adverse effects in patients on pharmacological therapy
  • Repeat stone analysis, when available, especially in patients not responding to treatment
  • Monitor patients w/ struvite stones for re-infection w/ urease-producing organisms & utilize strategies to prevent such occurrences
  • Obtain follow-up imaging studies to assess stone growth or new formation based on stone activity [eg plain abdominal imaging, renal ultrasound (UTZ) or low-dose computed tomography (CT) scan]
Editor's Recommendations
Most Read Articles
27 Sep 2017
Sleep problems appear to be associated with progression of lower urinary tract symptoms (LUTS) in men with the urologic condition and with LUTS development among asymptomatic men, according to data from the REDUCE* study.
Tristan Manalac, 10 Oct 2017
Despite being common, less than half of Singaporean women have sought medical attention for urinary incontinence for fear of surgery, embarrassment and other misconceptions, a new study from Singapore has found
03 Oct 2017
Use of alpha blockers, including silodosin, tamsulosin and alfuzosin, in the treatment of patients with benign prostatic hyperplasia is safe and effective in terms of improving lower urinary tract symptoms (LUTS) and quality of life (QoL), according to a study.
Yesterday
Physiotherapy and behaviour therapy appear to be effective interventions in females with overactive bladder syndrome, with those who have had no previous exposure to the treatments benefitting from post-therapy effects, a recent study has shown.